AdvanSix (NYSE:ASIX) Shares Down 0.6% – Should You Sell?

Shares of AdvanSix Inc. (NYSE:ASIX) fell 0.6% during trading on Monday . The stock traded as low as $31.92 and last traded at $32.29. 22,482 shares changed hands during trading, a decline of 84% from the average session volume of 140,881 shares. The stock had previously closed at $32.47.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on ASIX shares. Piper Sandler lifted their price objective on shares of AdvanSix from $35.00 to $39.00 and gave the company an “overweight” rating in a research report on Friday, November 8th. StockNews.com lowered shares of AdvanSix from a “buy” rating to a “hold” rating in a research report on Tuesday, November 19th.

AdvanSix Price Performance

The company has a quick ratio of 0.62, a current ratio of 1.34 and a debt-to-equity ratio of 0.28. The company has a market capitalization of $872.73 million, a PE ratio of 22.90 and a beta of 1.69. The firm’s 50 day simple moving average is $30.26 and its 200 day simple moving average is $27.32.

AdvanSix Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, November 26th. Shareholders of record on Tuesday, November 12th were given a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 1.96%. The ex-dividend date was Tuesday, November 12th. AdvanSix’s dividend payout ratio (DPR) is presently 45.39%.

Insider Transactions at AdvanSix

In other news, insider Christopher Gramm sold 1,951 shares of the firm’s stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $32.00, for a total value of $62,432.00. Following the transaction, the insider now owns 43,463 shares in the company, valued at $1,390,816. This trade represents a 4.30 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Erin N. Kane sold 5,000 shares of the company’s stock in a transaction on Friday, November 1st. The shares were sold at an average price of $30.37, for a total value of $151,850.00. Following the completion of the sale, the chief executive officer now owns 517,795 shares of the company’s stock, valued at approximately $15,725,434.15. The trade was a 0.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 15,369 shares of company stock valued at $474,058. 5.60% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On AdvanSix

A number of hedge funds have recently modified their holdings of ASIX. Point72 DIFC Ltd purchased a new stake in shares of AdvanSix in the second quarter valued at $34,000. Acadian Asset Management LLC acquired a new stake in shares of AdvanSix in the second quarter worth $36,000. Copeland Capital Management LLC acquired a new position in shares of AdvanSix during the third quarter worth about $41,000. Allspring Global Investments Holdings LLC purchased a new position in AdvanSix in the 2nd quarter worth approximately $51,000. Finally, Point72 Asia Singapore Pte. Ltd. acquired a new stake in AdvanSix during the 2nd quarter valued at $51,000. 86.39% of the stock is currently owned by hedge funds and other institutional investors.

AdvanSix Company Profile

AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.